NYSE:BAXMedical Equipment
Baxter’s Post-Divestiture Profit Focus Might Change The Case For Investing In Baxter International (BAX)
In recent months, Baxter International has completed the divestiture of its Kidney Care business and reported modest sales growth with improving operating cash flow, underscoring progress after its portfolio simplification.
This tighter focus on a medtech and hospital-products platform with a large installed base and recurring consumables demand is sharpening attention on margin improvement and cash conversion across the remaining business.
Next, we’ll explore how Baxter’s sharpened...